微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 67% | -10.2% | -3.67% | 31/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 69.56% | -5.79% | -2.78% | 26/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 71.55% | 1.07% | -2.26% | 18/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 73.2% | 2.59% | -1.89% | 15/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 74.61% | 7.91% | 1.06% | 14/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 73.83% | 2% | 4.3% | 19/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 70.79% | 2.48% | -0.8% | 23/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 71.36% | 2% | 3.2% | 24/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 69.15% | 3.76% | 0.11% | 32/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 69.07% | 2.01% | 2.01% | 29/141 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2022-12-31 | 67.71% | 1.49% | 1.6% | 35/141 | 54.01% | 正海生物 | 89.9% | 行业排名> |
| 2022-06-30 | 66.64% | 2% | -0.11% | 39/141 | 55.37% | 正海生物 | 90.39% | 行业排名> |
| 2021-12-31 | 66.71% | 3.8% | 3.8% | 47/141 | 57.98% | 正海生物 | 90.3% | 行业排名> |
| 2020-12-31 | 64.27% | -5.1% | -5.1% | 61/141 | 60.12% | 万泰生物 | 91.61% | 行业排名> |
| 2019-12-31 | 67.72% | 2% | 2% | 41/141 | 56.96% | 三友医疗 | 90.18% | 行业排名> |